Skip to search.
 TSX Up 0.07% TSX Ventures  0.00%
Streaming
Ticker Tape: On

Novavax, Inc. (NVAX)

-NasdaqGS

2.02 Down 0.02(0.98%) May 24, 4:00PM EDT

Add to Portfolio
Prev Close:2.04
Open:2.02
Bid:1.95 x 4100
Ask:2.27 x 6000
1y Target Est:4.21
Beta:1.3
Next Earnings Date:29-Jul-13NVAX Earnings announcement
Day's Range:2.00 - 2.05
52wk Range:1.20 - 2.77
Volume:512,057
Avg Vol (3m):1,459,430
Market Cap:305.45M
P/E (ttm):N/A
EPS (ttm):-0.23
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NVAXDown 0.98%305.45M
RHHBYN.MXUp 0.14%2.66T
SHP.LUp 1.59%11.96B
SUNPHARMA.NSDown 3.69%1.00T
GILD.MXDown 1.48%1.04T

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):14.50
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-13) :-0.24
Quarterly EPS Est (Jun-13) :-0.06
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on developing recombinant protein nanoparticle vaccines to address a range of infectious diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback